Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119382) titled 'Single arm, single center, phase II study of benmelstobart combined with GC regimen and lurasidone as first-line treatment for advanced biliary system tumors' on Feb. 26.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Wuxi people's Hospital

Condition: Locally advanced or metastatic malignant biliary tract tumors

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-01

Target Sample Size: Trial Group:52;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=310176

Published by HT Digital Content Servic...